Role of pituitary adenylate-cyclase activating polypeptide and tac1 gene derived tachykinins in sensory, motor and vascular functions under normal and neuropathic conditions

Peptides

Volumn 43, Issue , 2013, Pages 105-112

  Botz, Bálint ^a   Imreh, András ^a   Sándor, Katalin ^a   Elekes, Krisztián ^a   Szolcsányi, János ^a   Reglodi, Dóra ^a   Quinn, John P ^b   Stewart, James ^b   Zimmer, Andreas ^c   Hashimoto, Hitoshi ^d   Helyes, Zsuzsanna ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c UNIVERSITY OF BONN   (Germany)

^d OSAKA UNIVERSITY   (Japan)

Author keywords

Mechanical hyperalgesia; Neurogenic vasodilation; Sciatic nerve ligation; Substance P; Tachykinin NK1 receptor; Traumatic mononeuropathy

Indexed keywords

ALLYL ISOTHIOCYANATE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; TAC1 PROTEIN; TACHYKININ DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN MICROCIRCULATION; CONTROLLED STUDY; MONONEUROPATHY; MOTOR COORDINATION; MOTOR PERFORMANCE; MOUSE; NERVE LIGATION; NONHUMAN; PRIORITY JOURNAL; SCIATIC NERVE; SENSORY NERVE; TISSUE DOPPLER IMAGING; VASODILATATION;

ANIMALS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOTOR ACTIVITY; NEOVASCULARIZATION, PHYSIOLOGIC; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; RECEPTORS, NEUROKININ-1; SENSORY RECEPTOR CELLS; TACHYKININS;

ANIMALIA; MUS;

EID: 84875385920     PISSN: 01969781     EISSN: 18735169     Source Type: Journal    
DOI: 10.1016/j.peptides.2013.03.003     Document Type: Article

References (65)

1. P. Anand, and K. Bley Topical capsaicin for pain management: therapeutic potential and mechanisms of action of the new high-concentration capsaicin 8% patch Br J Anaesth 107 2011 490 502
2. C.M. Cahill, and T.J. Coderre Attenuation of hyperalgesia in a rat model of neuropathic pain after intrathecal pre- or post-treatment with a neurokinin-1 antagonist Pain 95 2002 277 285
3. S. Caioli, L. Curcio, M. Pieri, A. Antonini, R. Marolda, and C. Severini Substance P receptor activation induces downregulation of the AMPA receptor functionality in cortical neurons from a genetic model of Amyotrophic Lateral Sclerosis Neurobiol Dis 44 2011 92 101
4. N. Charkoudian Mechanisms and modifiers of reflex induced cutaneous vasodilation and vasoconstriction in humans J Appl Physiol 109 2010 1221 1228
5. M. Coudoré-Civiale, C. Courteix, M. Boucher, J. Fialip, and A. Eschalier Evidence for an involvement of tachykinins in allodynia in streptozocin-induced diabetic rats Eur J Pharmacol 401 2000 47 53
6. R. Davis-Traber, S. Baker, S.G. Lehto, C. Zhong, C.S. Surowy, and C.R. Faltynek Central pituitary adenylate cylase 1 receptors modulate nociceptive behaviours in both inflammation and neuropathic pain states J Pain 9 2008 449 456
7. Y. De Koninck, and J.L. Henry Substance P-mediated slow excitatory postsynaptic potential elicited in dorsal horn neurons in vivo by noxious stimulation Proc Natl Acad Sci USA 88 1991 11344 11348
8. T. Dickinson, and S.M. Fleetwood-Walker VIP and PACAP: very important in pain? Trends Pharmacol Sci 20 1999 324 329
9. E. Ekblad Pharmacological evidence for both neuronal and smooth muscular PAC1 receptors and a VIP-specific receptor in rat colon Regul Pept 85 1999 87 92
10. K. Elekes, K. Sandor, A. Moricz, L. Kereskai, A. Kemeny, and E. Szoke Pituitary adenylate cyclase-activating polypeptide plays an anti-inflammatory role in endotoxin-induced airway inflammation: in vivo study with gene-deleted mice Peptides 32 2011 1439 1446
11. J.R. Goff, A.R. Burkey, D.J. Goff, and L. Jasmin Reorganization of the spinal dorsal horn in models of chronic pain: correlation with behaviour Neuroscience 82 1998 559 574
12. M.I. Gonzalez, M.J. Field, J. Hughes, and L. Singh Evaluation of selective NK1 receptor antagonist CI-1021 in animal models of inflammatory and neuropathic pain J Pharmacol Exp Ther 294 2000 444 450
13. S. Harrison, P. Geppetti, and P. Substance Int J Biochem Cell Biol 33 2001 555 576
14. H. Hashimoto, N. Shintani, K. Tanaka, W. Mori, M. Hirose, and T. Matsuda Altered psychomotor behaviors in mice lacking pituitary adenylate cyclase-activating polypeptide (PACAP) Proc Natl Acad Sci USA 98 2001 13355 13360
15. H. Hastrup, and T.W. Schwartz Septide and neurokinin A are high-affinity ligands on the NK-1 receptor: evidence from homologous versus heterologous binding analysis FEBS Lett 399 1996 264 266
16. Z. Helyes, K. Elekes, K. Sandor, I. Szitter, L. Kereskai, and E. Pinter Involvement of preprotachykinin A gene-encoded peptides and the neurokinin 1 receptor in endotoxin-induced murine airway inflammation Neuropeptides 44 2010 399 406
17. Helyes Zs, G. Pozsgai, R. Borzsei, J. Nemeth, T. Bagoly, and L. Mark Inhibitory effect of PACAP-38 on acute neurogenic and non-neurogenic inflammatory processes in the rat Peptides 28 2007 1847 1855
18. P. Holzer Capsaicin: cellular targets, mechanisms of action, and selectivity for thin sensory neurons Pharmacol Rev 43 1991 143 201
19. P. Holzer Neurogenic vasodilatation and plasma leakage in the skin Gen Pharmacol 30 1998 5 11
20. H. Jongsma, N. Danielsen, F. Sundler, and M. Kanje Alteration of PACAP distribution and PACAP receptor binding in the rat sensory nervous system following sciatic nerve transection Brain Res 85 2000 186 196
21. L. Kahsai, J.R. Martin, and A.M. Winther Neuropeptides in the Drosophila central complex in modulation of locomotor behavior J Exp Biol 213 2010 2256 2265
22. M. Laburthe, A. Couvineau, and V. Tan Class II G-protein-coupled receptors for VIP and PACAP: structure, models of activation and pharmacology Peptides 28 2007 1631 1639
23. A. Lecci, and C.A. Maggi Peripheral tachykinin receptors as potential therapeutic targets in visceral diseases Expert Opin Ther Targets 7 2003 343 362
24. Q. Lin, D. Li, X. Xu, X. Zou, and L. Fang Roles of TRPV1 and neuropeptidergic receptors in dorsal root reflex-mediated neurogenic inflammation induced by intradermal injection of capsaicin Mol Pain 25 3 2007 30
25. T. Mabuchi, N. Shintani, S. Matsumura, E. Okuda-Ashitaka, H. Hashimoto, and T. Muratani Pituitary adenylate cyclase-activating polypeptide is required for the development of spinal sensitization and induction of neuropathic pain Neuroscience 24 2004 7283 7291
26. C.A. Maggi The mammalian tachykinin receptors Gen Pharmacol 26 1995 911 944
27. C.A. Maggi, and T.W. Schwartz The dual nature of the tachykinin NK1 receptor Trends Pharmacol Sci 18 1997 351 355
28. A.B. Malmberg, and A.I. Basbaum Partial sciatic nerve injury in the mouse as a model of neuropathic pain: behavioural and neuroanatomical correlates Pain 76 1998 215 222
29. A. Markovics, V. Kormos, B. Gaszner, A. Lashgarara, E. Szoke, and K. Sandor Pituitary adenylate cyclase activating polypeptide plays a key role in nitroglycerol-induced trigeminovascular activation in mice Neurobiol Dis 45 2012 633 644
30. P. Marquez, D. Bebawy, V. Lelièvre, A.C. Coûté, C.J. Evans, and J.A. Waschek The role of endogenous PACAP in motor stimulation and conditioned place preference induced by morphine in mice Psychopharmacology (Berlin) 20 2009 457 463
31. A. Miyata, A. Arimura, R.R. Dahl, N. Minamino, A. Uehara, and L. Jiang Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells Biochem Biophys Res Commun 164 1989 567 574
32. J.S. Mogil, S.G. Wilson, K. Bon, S.E. Lee, K. Chung, and P. Raber Heritability of nociception I: responses of 11 inbred mouse strains on 12 measures of nociception Pain 80 1999 67 82
33. K. Moller, Y.Z. Zhang, R. Hakanson, A. Luts, B. Sjolund, and R. Uddman Pituitary adenylate cyclase activating peptide is a sensory neuropeptide: immunocytochemical and immunochemical evidence Neuroscience 57 1993 725 732
34. H. Mulder, H. Jongsma, Y.Z. Zhang, S. Gebre-Medhin, F. Sundler, and N. Danielsen Pituitary adenylate cyclase activating polypeptide and islet amyloid polypeptide in primary sensory neurons: functional implications from plasticity in expression on nerve injury and inflammation Mol Neurobiol 19 1999 229 253
35. M. Narita, S.L. Dun, N.J. Dun, and L.F. Tseng Hyperalgesia induced by pituitary adenylate cyclase activating polypeptide in the mouse spinal cord Eur J Pharmacol 311 1996 121 126
36. J. Nemeth, D. Reglodi, G. Pozsgai, A. Szabo, K. Elekes, and E. Pinter Effect of pituitary adenylate cyclase activating polypeptide-38 on sensory neuropeptide release and neurogenic inflammation in rats and mice Neuroscience 143 2006 223 230
37. M. Ohsawa, G.C. Brailoiu, M. Shiraki, N.J. Dun, K. Paul, and L.F. Tseng Modulation of nociceptive transmission by pituitary adenylate cyclase activating polypeptide in the spinal cord of the mouse Pain 100 2002 27 34
38. N.M. Page New challenges in the study of the mammalian tachykinins Peptides 26 2005 1356 1368
39. L.M. Pettersson, T. Heine, V.M. Verge, F. Sundler, and N. Danielsen PACAP mRNA is expressed in rat spinal cord neurons J Comp Neurol 471 2004 85 96
40. F.M. Pinto, T.A. Almeida, M. Hernandez, P. Devillier, C. Advenier, and M.L. Candenas mRNA expression of tachykinins and tachykinin receptors in different human tissues Eur J Pharmacol 494 2004 233 239
41. Y. Sakashita, D. Kurihara, T. Uchida, I. Tatsuno, and T. Yamamoto Involvement of PACAP receptor in primary afferent fibre-evoked responses of ventral roots in the neonatal rat spinal cord Br J Pharmacol 132 2001 1769 1776
42. K. Sandor, K. Bolcskei, J. McDougall, N. Schuelert, D. Reglodi, and K. Elekes Divergent peripheral effects of pituitary adenylate cyclase activating polypeptide-38 on nociception in rats and mice Pain 141 2009 143 150
43. K. Sandor, Z. Helyes, K. Gyires, J. Szolcsányi, and J. Laszlo Static magnetic field-induced anti-nociceptive effect and the involvement of capsaicin-sensitive sensory nerves in this mechanism Life Sci 81 2007 97 102
44. K. Sándor, V. Kormos, B. Botz, A. Imreh, K. Bolcskei, and B. Gaszner Impaired nocifensive behaviours and mechanical hyperalgesia, but enhanced thermal allodynia in pituitary adenylate cyclase-activating polypeptide deficient mice Neuropeptides 44 2010 363 371
45. H.W. Schytz, H. Holst, L. Arendt-Nielsen, J. Olesen, and M. Ashina Cutaneous nociception and neurogenic inflammation evoked by PACAP38 and VIP J Headache Pain 11 2010 309 316
46. H.W. Schytz, J. Olesen, and M. Ashina The PACAP receptor: a novel target for migraine treatment Neurotherapeutics 7 2010 191 196
47. Z. Seltzer, R. Dubner, and Y. Shir A novel behavioural model of neuropathic pain disorders produced in rats by partial sciatic nerve injury Pain 43 1990 205 218
48. T. Shimizu, M. Katahira, H. Sugawara, K. Inoue, and A. Miyata Diverse effects of intrathecal pituitary adenylate cyclase-activating polypeptide on nociceptive transmission in mice spinal cord Regul Pept 123 2004 117 122
49. S.B. Smith, S.E. Crager, and J.S. Mogil Paclitaxel-induced neuropathic hypersensitivity in mice: responses in 10 inbred mouse strains Life Sci 74 2004 2593 2604
50. A. Somogyvari-Vigh, and D. Reglodi Pituitary adenylate cyclase activating polypeptide: a potential neuroprotective peptide Curr Pharm Des 10 2004 2861 2889
51. A. Szallasi, and P.M. Blumberg Vanilloid (capsaicin) receptors and mechanisms Pharmacol Rev 51 1999 159 212
52. Y. Tatsushima, N. Egashira, T. Kawashiri, Y. Mihara, T. Yano, and K. Mishima Involvement of substance P in peripheral neuropathy induced by paclitaxel but not oxaliplatin J Pharmacol Exp Ther 337 2011 226 235
53. E. Thornton, and R. Vink Treatment with a substance P receptor antagonist is neuroprotective in the intrastriatal 6-hydroxydopamine model of early Parkinson's disease PLoS ONE 7 2012 e34138
54. B. Tuka, Z. Helyes, A. Markovics, T. Bagoly, J. Németh, and L. Márk Peripheral and central alterations of pituitary adenylate cyclase activating polypeptide-like immunoreactivity in the rat in response to activation of the trigeminovascular system Peptides 33 2012 307 316
55. D. Vaudry, A. Falluel-Morel, S. Bourgault, M. Basille, D. Burel, and O. Wurtz Pituitary adenylate cyclase-activating polypeptide and its receptors: 20 years after the discovery Pharmacol Rev 61 2009 283 357
56. H. Vedder, and U. Otten Biosynthesis and release of tachykinins from rat sensory neurons in culture J Neurosci Res 30 1991 288 299
57. J. Wallin, E. Schött, and Substance P release in the spinal dorsal horn following peripheral nerve injury Neuropeptides 36 2002 252 256
58. D.A. Walsh, and F.D. McWilliams Tachykinins and the cardiovascular system Curr Drug Targets 7 2006 1031 1042
59. B.J. Wong, and C.T. Minson Neurokinin-1 receptor desensitization attenuates cutaneous active vasodilatation in humans J Physiol 577 2006 1043 1051
60. X.J. Xu, and Z. Wiesenfeld-Hallin Intrathecal pituitary adenylate cyclase activating polypeptide facilitates the spinal nociceptive flexor reflex in the rat Neuroscience 72 1996 801 804
61. Y. Zhang, N. Danielsen, F. Sundler, and H. Mulder Pituitary adenylate cyclase-activating peptide is upregulated in sensory neurons by inflammation Neuroreport 9 1998 2833 2836
62. Y. Zhang, A.B. Malmberg, B. Sjolund, and T.L. Yaksh The effect of pituitary adenylate cyclase activating peptide (PACAP) on the nociceptive formalin test Neurosci Lett 207 1996 187 190
63. Y. Zhang, A.B. Malmberg, T.L. Yaksh, B. Sjölund, F. Sundler, and R. Håkanson Capsaicin-evoked release of pituitary adenylate cyclase activating peptide (PACAP) and calcitonin gene-related peptide (CGRP) from rat spinal cord in vivo Regul Pept 69 1997 83 87
64. C.J. Zhou, S. Shioda, T. Yada, N. Inagaki, S.J. Pleasure, and S. Kikuyama PACAP and its receptors exert pleiotropic effects in the nervous system by activating multiple signaling pathways Curr Protein Pept Sci 3 2002 423 439
65. M. Zimmermann Ethical guidelines for investigations of experimental pain in conscious animals Pain 16 1983 109 110